To better understand whether the decreased salivary lactoferrin levels are specific to AD and thus suitable for its diagnosis, the same research group performed a second study in which the relationship was examined between salivary lactoferrin and cerebral Aβ load in patients with aMCI, AD, frontotemporal dementia (FTD)—as an example of another type of dementia—and a healthy control group [91]. The gene discussed is LTF; the disease is dementia.